A year after GSK pulled its BCMA-targeting antibody-drug conjugate (ADC) Blenrep from the US market as a later-line therapy for multiple myeloma, there are signs that the drug may still have a ...

The Mazagan fortress with its ditch and inclined ramparts is one of the first testimonies in the Lusitanian period of the application by Portuguese technology of new architectural concepts of ...